| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/21/2002 | EP1232262A2 Recombinant gelatin in vaccines |
| 08/21/2002 | EP1232259A1 Human galanin family proteins and polynucleotides encoding the same |
| 08/21/2002 | EP1232258A1 Colon tumour-associated antigens |
| 08/21/2002 | EP1232257A2 Modular transport systems for molecular substances and production and use thereof |
| 08/21/2002 | EP1232245A1 Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders |
| 08/21/2002 | EP1232181A2 Recombinant gelatins |
| 08/21/2002 | EP1232179A1 15 human secreted proteins |
| 08/21/2002 | EP1232177A2 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 08/21/2002 | EP1232165A1 Phosphorus-containing dendrimers as transfection agents |
| 08/21/2002 | EP1232157A2 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 08/21/2002 | EP1231926A2 New complex, and methods for its production and use |
| 08/21/2002 | EP1231910A2 Inhibitors of endo-exonuclease activity such as pentamidine for treating cancer |
| 08/21/2002 | EP1231895A1 Modular targeted liposomal delivery system |
| 08/21/2002 | EP1231840A1 Anti-angiogenic cellular agent for cancer therapy |
| 08/21/2002 | EP1231836A2 Human ex vivo immune system |
| 08/21/2002 | EP1178835A4 Compositions and methods for improving learning and memory |
| 08/21/2002 | EP0804456B1 Peptide nucleic acid conjugates |
| 08/21/2002 | EP0752882B1 Treatment for diabetes |
| 08/21/2002 | CN1365392A Drosophila recombination-associated protein and methods for use |
| 08/21/2002 | CN1365388A Virus envelope vector for gene transfer |
| 08/21/2002 | CN1365285A Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvia area |
| 08/21/2002 | CN1089344C Inhibitor of stem cell proliferation and uses thereof |
| 08/20/2002 | US6437117 Synthesis, deprotection, analysis and purification for RNA and ribozymes |
| 08/20/2002 | US6436909 Antisense inhibition of transforming growth factor-β expression |
| 08/20/2002 | US6436908 Administering to cardiac muscle of mammal via cardiac perfusion expression vector comprising promoter active in myocardium operably linked to dna sequence encoding beta adrenergic receptor kinase 1 inhibitor |
| 08/20/2002 | US6436907 Adenovirus-medicated gene transfer to cardiac and vascular smooth muscle |
| 08/20/2002 | US6436708 Delivery system for gene therapy to the brain |
| 08/20/2002 | US6436700 Anti-sense p21 k-ras |
| 08/20/2002 | US6436693 Using dna helper virus vector dna mutated so that cis-acting signal sequences for packaging of dna are non-functional; helper virus dna may provide information necessary for production of viral particles but may not be packaged therein |
| 08/20/2002 | US6436670 Gene and uses therefor |
| 08/20/2002 | US6436667 Isolated polynucleotide, or complement thereof, comprising specified polynucleotide sequence, which encodes polypeptide which promotes development of pancreatic beta cells |
| 08/20/2002 | US6436648 Chimeric viral proteins |
| 08/20/2002 | US6436644 Enzymatic nucleic acid cleaves rna; inflammation and autoimmune disease treatment; medical diagnosis |
| 08/20/2002 | US6436642 Method of classifying a thyroid carcinoma using differential gene expression |
| 08/20/2002 | US6436634 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 08/20/2002 | US6436394 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 08/20/2002 | US6436393 Adenoviral vector encoding anti-apoptotic Bcl-2 gene and uses thereof |
| 08/20/2002 | US6436392 Dna segment confers increased episomal stability, persistence or abundance of the isolated dna molecule in a host cell |
| 08/20/2002 | CA2210353C Stabilized external guide sequences |
| 08/20/2002 | CA2203991C Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/15/2002 | WO2002063025A2 Muscle-directed gene therapy with aav-1 and aav-6 vectors |
| 08/15/2002 | WO2002063015A1 Aspartyl protease |
| 08/15/2002 | WO2002063008A2 Intracellular signaling molecules |
| 08/15/2002 | WO2002063004A2 G-protein coupled receptors |
| 08/15/2002 | WO2002063000A2 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same |
| 08/15/2002 | WO2002062999A2 Proteins and nucleic acids encoding same |
| 08/15/2002 | WO2002062994A1 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 08/15/2002 | WO2002062959A2 Hepatitis b virus treatment |
| 08/15/2002 | WO2002062945A2 Compositions and methods relating to lung specific genes and proteins |
| 08/15/2002 | WO2002062845A2 Adhesion molecules |
| 08/15/2002 | WO2002062840A1 INTERFERON-α INDUCED GENE |
| 08/15/2002 | WO2002062834A2 Mixture of peptides originating from a nef protein and applications thereof |
| 08/15/2002 | WO2002062823A2 Peptides for facilitating composite receptor expression and translocation of macromolecules |
| 08/15/2002 | WO2002062820A2 Haplotypes of the cyp27b1 gene |
| 08/15/2002 | WO2002062205A2 Methods for diagnosing and treating heart disease |
| 08/15/2002 | WO2002062204A2 Methods for diagnosing and treating heart disease |
| 08/15/2002 | WO2002051858A3 Antisense modulation of chk2 expression |
| 08/15/2002 | WO2002024932A3 Expression vectors containing hybrid ubiquitin promoters |
| 08/15/2002 | WO2002022160A3 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 08/15/2002 | WO2002020732A3 Regulation of human map kinase phosphatase-like enzyme |
| 08/15/2002 | WO2002019966A3 Cardiac arrhythmia treatment methods |
| 08/15/2002 | WO2002008751A3 Mild enrichment of foetal cells from peripheral blood and use thereof |
| 08/15/2002 | WO2001072825A3 Apoptin-associating protein |
| 08/15/2002 | WO2001072824A3 Apoptin-associating protein |
| 08/15/2002 | WO2001066572A9 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 08/15/2002 | WO2001034801A9 Recombinant gelatin in vaccines |
| 08/15/2002 | WO2001034625A9 Isolation and characterization of human nf-e4 |
| 08/15/2002 | WO2001032843A9 Enhanced immune recognition of pathogenic cells by icsbp expression |
| 08/15/2002 | WO2001032222A9 Selective toxin expression in angiogenic endothelial cells |
| 08/15/2002 | WO2001029232A9 Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage |
| 08/15/2002 | WO2001019856A3 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 08/15/2002 | US20020111695 Reconstituted mineralized cartilage tissue |
| 08/15/2002 | US20020111502 Cholic acid or deoxycholic acid derivatives can include polypeptides, polynucleotides such as genes and antisense nucleic acids that can modulate cellular activity |
| 08/15/2002 | US20020111467 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/15/2002 | US20020111326 Using quaternary ammonium compound |
| 08/15/2002 | US20020111324 Adeno-associated virus-mediated delivery of angiogenic factors |
| 08/15/2002 | US20020111323 Genetic engineering |
| 08/15/2002 | US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 08/15/2002 | US20020111303 Protein found in breast, prostate gland cells cancer membrane |
| 08/15/2002 | US20020111294 Administering an organocobalt complex |
| 08/15/2002 | US20020110898 Attenuating endogenous genes in cell; obtain cell, transform with vectors conding restriction enzymes, recover and propagate transformed cells |
| 08/15/2002 | US20020110896 Expression vector coding envelope protein for use in prevention and treatment of infections; for use in gene therapy |
| 08/15/2002 | US20020110892 Human RNase H and compositions and uses thereof |
| 08/15/2002 | US20020110870 Therapeutic applications for CCR5 chemokine receptors |
| 08/15/2002 | US20020110853 Polypeptide; for use in the treatment of tumors |
| 08/15/2002 | US20020110841 Regulation of cell growth by MUC1 |
| 08/15/2002 | US20020110836 PD-L2 molecules: novel PD-1 ligands and uses therefor |
| 08/15/2002 | US20020110805 Peptide for use in the treatment of glomerulonephritis, psoriasis, leukemia, antherosclerosis, autoimmune diseases, inflammatory, arthritic, asthmatic, and fibrotic disorders |
| 08/15/2002 | US20020110566 Administering fusion protein comprising a heat shock protein (hsp) or an immunostimulatory fragment thereof, and protein of a human papilloma virus (HPV), or an antigenic fragment thereof, for therapy of wart |
| 08/15/2002 | US20020110565 Viral vectors having enhanced effectiveness with reduced virulence |
| 08/15/2002 | US20020110559 Confering an immune response to a tumor cell in a mammal by administering antibody which binds to aspartyl (asparaginyl) beta hydroxylase (HAAH) |
| 08/15/2002 | US20020110547 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 08/15/2002 | US20020110546 Implanting cells of an immortalized human neuro-derived fetal cell line into the host for therapy |
| 08/15/2002 | US20020110545 Adenovector pharmaceutical composition |
| 08/15/2002 | US20020110543 Viral delivery system for infectious transfer of large genomic DNA inserts |
| 08/15/2002 | US20020110540 Disease prevention by reactivation of the thymus |
| 08/15/2002 | US20020110539 Modulated release particles for lung delivery |
| 08/15/2002 | US20020110535 Multivalent platform molecules comprising high molecular weight polyethylene oxide |
| 08/15/2002 | US20020110526 Modulated release particles for lung delivery |
| 08/15/2002 | US20020108217 Jewelry closure |